Sign in

CIK 0001738021

  • Non-accelerated filer
  • Smaller reporting company

Compass Therapeutics, Inc.

Sign in to watch
Ticker
CMPX
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
Phone
+1 617-500-8099
Business address
80 GUEST STREET, BOSTON, MA, 02135
Former names
Olivia Ventures, Inc.
Open-market buys, last 90 days
$27,150
in 3 filings
Open-market sales, last 90 days
$0
in 0 filings

Net +$27,150. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Lerner Neil +$27K Chief Accounting Officer 3 filings
Date Insider Transaction Shares Price Value Owned after
2026-11-17 Lerner Neil Chief Accounting Officer Purchase +10,000 $0.59 $6K 430,000
2026-10-01 Lerner Neil Chief Accounting Officer Purchase +20,000 $0.92 $18K 420,000
2026-09-24 Lerner Neil Chief Accounting Officer Purchase +2,500 $1.14 $3K 400,000
2026-04-29 Lerner Neil Chief Accounting Officer Purchase +15,000 $1.89 $28K 397,500
2026-04-29 Anderman Jonathan General Counsel Purchase +25,000 $1.89 $47K 196,000
2026-04-29 Anderman Jonathan General Counsel Grant or award +25,000 $1.89 $47K 196,000
2026-04-29 Lerner Neil Chief Accounting Officer Grant or award +15,000 $1.89 $28K 397,500
2026-02-08 Schuetz Thomas J. CHIEF EXECUTIVE OFFICER Shares withheld for taxes −36,687 $6.52 $239K 6,603,336
2026-01-09 Schuetz Thomas J. CHIEF EXECUTIVE OFFICER Shares withheld for taxes −46,777 $5.35 $250K 6,640,023
2026-01-02 Shin Barry CFO Grant or award +125,000 $5.17 $646K 525,000
2026-01-02 Shin Barry CFO Grant or award · Stock Option (Right to Buy) +670,000 670,000
2026-01-02 Sirard Cynthia Chief Medical Officer Grant or award · STOCK OPTION (RIGHT TO BUY) +1,000,000 1,000,000
2026-01-02 Schuetz Thomas J. CEO Grant or award +250,000 $5.17 $1.3M 6,686,800
2026-01-02 Schuetz Thomas J. CEO Grant or award · Stock Option (Right to Buy) +2,000,000 2,000,000
2026-01-02 Prasad Arjun Chief Commercial Officer Grant or award · STOCK OPTION (RIGHT TO BUY) +1,000,000 1,000,000
2026-01-02 LINDAHL RICHARD S Director Grant or award · Stock Option (Right to Buy) +90,000 90,000
2026-01-02 Chiniara Ellen Director Grant or award · Stock Option (Right to Buy) +90,000 90,000
2026-01-02 Lerner Neil Chief Accounting Officer Grant or award +62,500 $5.17 $323K 382,500
2026-01-02 Lerner Neil Chief Accounting Officer Grant or award · Stock Option (Right to Buy) +435,000 435,000
2026-01-02 GRAY MARY ANN Director Grant or award · Stock Option (Right to Buy) +90,000 90,000

Page 1 of 8 · 144 trades